The adoption of advanced technological tools in clinical trials is accelerating as sponsors seek faster insights, stronger compliance, and improved decision-making. In an article for Applied Clinical Trials, Christian Schmidt, Associate Director at Phastar, explains how combining tech innovation with deep therapeutic expertise can transform complex trial data into clear, actionable intelligence.
”Customizable tools can enable users without statistics or programming backgrounds to analyze data themselves and get the insights in real time, reducing the waiting time for analysis. These tools can also help with budget control, particularly in small biotech organizations which do not have the budget or demand to hire a programmer or data manager.”